Related Experiment Videos
Vitamin E and discoid lupus erythematosus
J A Yell1, S Burge, F Wojnarowska
1Department of Dermatology, Slade Hospital, Oxford, UK.
Lupus
|October 1, 1992
Summary
This study investigated Vitamin E for discoid lupus erythematosus (DLE). Oral Vitamin E did not clear DLE lesions in seven patients, though no adverse effects were observed during the trial.
Area of Science:
- Dermatology
- Immunology
- Nutritional Science
Background:
- Discoid lupus erythematosus (DLE) is a chronic autoimmune condition affecting the skin.
- Limited effective treatments exist, and patients often experience flares during summer months.
- Investigating novel therapeutic options is crucial for managing DLE.
Purpose of the Study:
- To evaluate the efficacy of oral Vitamin E in treating discoid lupus erythematosus.
- To assess the safety and tolerability of Vitamin E in DLE patients.
Main Methods:
- A trial involving seven patients with DLE was conducted.
- Patients received oral Vitamin E (400 mg three times daily) for 12 weeks.
- All other treatments were paused, with follow-up for at least 4 weeks post-treatment.
Main Results:
- No patient achieved complete clearing of DLE lesions.
- No significant deterioration of DLE activity was observed during the trial.
- No adverse side effects associated with Vitamin E supplementation were reported.
Conclusions:
- Oral Vitamin E at the tested dosage and duration showed no efficacy in clearing DLE lesions.
- Vitamin E appears to be safe and well-tolerated in DLE patients.
- Further research with different dosages or in combination therapies may be warranted.